Tue.May 28, 2024

article thumbnail

Takeda, amid restructuring campaign, plots 641 layoffs at two Massachusetts sites

Fierce Pharma

A recently announced $900 million restructuring drive is already making waves at Takeda, wi | From early July to March 2025, the Japanese drugmaker will cut 495 staffers at its Cambridge location and 146 in Lexington, Massachusetts. Takeda is the largest life sciences employer in the state.

338
338
article thumbnail

ONC Chief: New AI Transparency Rule Should Drive Higher Quality Tools & More AI Adoption

MedCity News

Micky Tripathi, head of The Office of the National Coordinator for Health Information Technology (ONC), thinks his office’s recent rule on AI transparency will spur greater adoption of AI tools in healthcare, as well as potentially drive higher quality AI-based products. The post ONC Chief: New AI Transparency Rule Should Drive Higher Quality Tools & More AI Adoption appeared first on MedCity News.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Data breach at pharma partner Cencora puts sensitive patient information at risk

Fierce Pharma

A data breach at drug distributor Cencora has left sensitive information vulnerable, with patients on medicines from a dozen drugmakers potentially affected. | The potentially compromised data included patient information such as names and addresses, Cencora disclosed in letters to patients who may have been affected.

Patients 315
article thumbnail

Lignin-based drug delivery system may improve chemotherapeutics

European Pharmaceutical Review

Researchers have defined the conditions to formulate novel polyelectrolyte complexes (PECs) based on a sustainable hemicellulose-rich lignosulphonate. Their findings suggest potential applications in drug delivery. Novel biomaterials based on PECs are being investigated in the industry as drug delivery systems, due to PECs being able to “to entrap drugs under mild conditions and control their release”.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Japan's Asahi Kasei puts up $1.06B offer to buy out Tarpeyo maker Calliditas

Fierce Pharma

Bolstered by a full FDA approval for its primary immunoglobulin A nephropathy (IgAN) treatment Tarpeyo, Calliditas has earned the attention of Japanese chemical giant Asahi Kasei. | Asahi Kasei has made a cash offer to acquire Calliditas in a deal worth 11.16 billion Swedish crowns ($1.06 billion), the companies announced Tuesday. Asahi’s bid represents a 74% premium to Calliditas' prior closing price.

FDA 269
article thumbnail

Ampoules packaging market forecast to 2033

European Pharmaceutical Review

A report by The Brainy Insights has predicted that the ampoules packaging market will value $9.83 billion by 2033. This is expected to be largely driven by increasing demand for this packaging type. A higher incidence of chronic diseases will propel growth of the market between 2024 and 2033, according to the data. Prospects of the ampoules packaging market On the other hand, advancements in ampoule packaging, as well as sustainability measures and manufacturing innovations such as automation an

More Trending

article thumbnail

CG Oncology Reveals Promising Results from Phase II CORE-001 Clinical Trial for the Treatment of BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer

Pharmaceutical Commerce

Results from the CORE-001 clinical trial are expected to be presented at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting.

105
105
article thumbnail

NS Pharma's Duchenne therapy Viltepso fails confirmatory trial

Fierce Pharma

Since NS Pharma launched its Duchenne muscular dystrophy (DMD) drug Viltepso (viltolarsen) in 2020, sales have steadily

Pharma 235
article thumbnail

J&J Adds Another Bispecific Antibody for Atopic Dermatitis With $1.25B Acquisition

MedCity News

Johnson & Johnson is acquiring a bispecific antibody that Numab Therapeutics engineered to address two pathways associated with the inflammation and itching of atopic dermatitis. It’s J&J’s second immunology acquisition this month. The post J&J Adds Another Bispecific Antibody for Atopic Dermatitis With $1.25B Acquisition appeared first on MedCity News.

article thumbnail

As weight loss booms, drugmakers look for an edge with oral options

PharmaVoice

Supply of GLP-1 medications falls well short of demand, and oral versions of the drugs loom over Eli Lilly and Novo Nordisk’s dominance.

Medical 98
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Insmed’s Trial Results Pave Way for FDA Filing in a Lung Disease With No Approved Therapies

MedCity News

Brensocatib, a drug Insmed licensed from AstraZeneca, met the main goal of a Phase 3 test in non-cystic fibrosis bronchiectasis. Insmed plans to seek regulatory approvals in this indication while also continuing to develop the small molecule for other inflammatory disorders. The post Insmed’s Trial Results Pave Way for FDA Filing in a Lung Disease With No Approved Therapies appeared first on MedCity News.

FDA 99
article thumbnail

FDA accepts Sanofi’s Sarclisa sBLA for priority review

Pharmaceutical Technology

The US FDA has accepted for priority review Sanofi's sBLA for Sarclisa regimen for transplant-ineligible newly diagnosed multiple myeloma.

FDA 94
article thumbnail

Yes, Agile Can Work in Medtech

MedCity News

Three tips to succeed in a highly regulated environment The post Yes, Agile Can Work in Medtech appeared first on MedCity News.

109
109
article thumbnail

QUT team receives US DoD funding for Parkinson’s treatment

Pharmaceutical Technology

Scientists of QUT have secured A$4m ($2.65m) grant from the US DoD for developing new treatments for Parkinson's disease.

98
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

HealthWell Foundation Unveils Fund to Help Patients Living with MASH

Pharmaceutical Commerce

Among its benefits, the fund will provide up to $8,000 in medication copayment or insurance premium assistance.

Insurance 105
article thumbnail

Trial readout sets up filings for Insmed bronchiectasis drug

pharmaphorum

Shares in Insmed double as phase 3 trial sets up filings for brensocatib, aiming to become the first approved drug for bronchiectasis

96
article thumbnail

How Women’s Health Conversations With Investors Have Evolved

MedCity News

The funding landscape for women’s health companies is getting better, partially due to more women getting promoted at VC firms and social media, execs said during a recent panel. The post How Women’s Health Conversations With Investors Have Evolved appeared first on MedCity News.

Media 85
article thumbnail

Ex-Jazz, Sunesis exec Swisher takes over at NodThera

pharmaphorum

NLRP3-focused biotech NodThera has named former Jazz Pharma and Sunesis executive Dan Swisher as its new CEO.

Pharma 103
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

MRC awards two medical research units at University of Cambridge ÂŁ30m in funding

PharmaTimes

The MRC BRC and the MDU will use the funding and cutting-edge research to improve public health until March 2029

Medical 94
article thumbnail

Pharma Pulse 5/28/24: Global Insulin Delivery Systems Strategic Research Report 2024, A Fun and Insightful Exploration of Behavioral Science & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 104
article thumbnail

LifeArc and ALS TDI announce partnership to develop new clinical tools for ALS and MND

PharmaTimes

The project will validate two minimally invasive biomarkers for ALS: MMP-9 and TIMP-1

99
article thumbnail

J&J snaps up atopic dermatitis drug in $1.25bn Numab deal

pharmaphorum

J&J agrees to buy Numab subsidiary Yellow Jersey and its NM26 bispecific antibody for atopic dermatitis in a $1.

73
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

The Case for Pharma, AI, and Israel: Q&A with Matti Gill

PharmExec

The CEO of AION Labs discusses both the new ways that AI is being implemented in drug development and why Israel is becoming the center of AI development in the pharma industry.

Pharma 52
article thumbnail

6 Patient Acquisition KPIs You Need to Track

Penrod

Importance of KPIs In Patient Acquisition Key performance indicators (KPIs) allow you to measure the effectiveness of your marketing efforts, helping you discern what works and what doesn’t – avoiding costly mistakes during patient intake. By consistently tracking these KPIs, you clearly understand how your patient acquisition strategies affect your bottom line.

article thumbnail

Compliance in Medical Sales: Strategies for Success

Rep-Lite

Compliance in medical sales encompasses a range of legal, ethical, and industry-specific requirements aimed at protecting patient safety, ensuring product quality, and maintaining integrity in sales practices. With stringent regulations, evolving guidelines, and increased scrutiny, compliance is essential for maintaining trust with stakeholders, avoiding legal issues, and sustaining business growth.

article thumbnail

ASCO 2024: J&J’s early radioligand prostate cancer trial reports four patient deaths

Pharmaceutical Technology

Nearly 37% of subjects experienced serious treatment-emergent adverse events, with thrombocytopenia and interstitial lung disease (ILD) being notable events.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Digital mental health start-up Spectrum.Life raises €17m

pharmaphorum

Digital health start-up Spectrum.Life raises €17m to drive international expansion of its mental health and wellbeing platform.

59
article thumbnail

FDA Grants Fast Track Designation to AV-001 for Moderate-to-Severe Acute Respiratory Distress Syndrome

PharmExec

Fast track designation for AV-001 comes amid promising results from a Phase I trial, which supported once-daily dosing and effective Tie2 activation.

FDA 52
article thumbnail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

PharmaTech

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

69
article thumbnail

J&J expands atopic dermatitis scope with $1.25bn Numab antibody purchase

Pharmaceutical Technology

J&J has made its second dermatology deal this month, adding Numab’s bispecific antibody NM26 to its growing atopic dermatitis drug portfolio.

52
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A